Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1090243 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR28402500_1.fastq.gz | Fastqsanger.gz | |||
| SRR28402500_2.fastq.gz | Fastqsanger.gz | |||
| SRR28402501_1.fastq.gz | Fastqsanger.gz | |||
| SRR28402501_2.fastq.gz | Fastqsanger.gz | |||
| SRR28402502_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 154 |
Similar Datasets
Project description:Air-liquid interface cultures are extensively used to model chronic respiratory diseases. Comparative transcriptomics between cultured cells and fresh nasal brushings from patients suggests a high degree of correlation.
2020-07-31 | GSE145096 | GEO
Project description:The aim of this study was to compare the transcriptomic response of airway cells from donors with different chronic respiratory diseases following SARS-CoV-2 infection. We used four reconstituted samples of airway epithelium from either healthy donors, donors with cystic fibrosis or donors with chronic obstructive pulmonary disease (COPD). These samples were uninfected or infected with SARS-CoV-2 at a multiplicity of infection (MOI) of 0.1 for 24, 48 and 72 hours.
2025-02-11 | E-MTAB-14481 | biostudies-arrayexpress
Project description:This series includes a 32-array training dataset used to evaluate E-Predict normalization and similarity metric parameters as well as 13 microarrays used as examples in (Urisman, et. al 2005). Training data set includes 15 independent HeLa RNAhybridizations (microarrays 1-15), 10 independent nasal lavage samples positive for Respiratory Syncytial virus (microarrays 16-25), and 7 independent nasal lavage samples positive for Influenza A virus (microarrays 26-32). Examples iclude a serum sample positive for Hepatitis B virus (microarray 33), a nasal lavage sample positive for both Influenza A virus and Respiratory Syncytial virus (microarray 34), and culture samples of 11 distinct Human Rhinovirus serotypes (microarrays 35-45). Keywords = virus detection, E-Predict, species identification, metagenomics
2010-06-10 | E-GEOD-2228 | biostudies-arrayexpress
Project description:BACKGROUND. Lower respiratory tract infection (LRTI) is a leading cause of death in children worldwide. LRTI diagnosis is challenging since non-infectious respiratory illnesses appear clinically similar and existing microbiologic tests are often falsely negative or detect incidentally-carried microbes common in children. These challenges result in antimicrobial overuse and adverse patient outcomes. Lower airway metagenomics has the potential to detect host and microbial signatures of LRTI. Whether it can be applied at scale and in a pediatric population to enable improved diagnosis and precision treatment remains unclear. METHODS. We used tracheal aspirate RNA-sequencing to profile host gene expression and respiratory microbiota in 261 children with acute respiratory failure. We developed a random forest gene expression classifier for LRTI by training on patients with an established diagnosis of LRTI (n=117) or of non-infectious respiratory failure (n=50). We then developed a classifier that integrates the: i) host LRTI probability, ii) abundance of respiratory viruses, and iii) dominance in the lung microbiome of bacteria/fungi considered pathogenic by a rules-based algorithm. RESULTS. The host classifier achieved a median AUC of 0.967 by 5-fold cross-validation, driven by activation markers of T cells, alveolar macrophages and the interferon response. The integrated classifier achieved a median AUC of 0.986 and significantly increased the confidence of patient classifications. When applied to patients with an uncertain diagnosis (n=94), the integrated classifier indicated LRTI in 52% of cases and nominated likely causal pathogens in 98% of those. CONCLUSIONS. Lower airway metagenomics enables accurate LRTI diagnosis and pathogen identification in a heterogeneous cohort of critically ill children through integration of host, pathogen, and microbiome features.
2022-12-06 | GSE212532 | GEO
Project description:Segmental instillation of lipopolysaccharide (LPS) by bronchoscopy can be used as a model to safely induce transient airway inflammation in the human lung. The LPS challenge model enables investigation of cellular mechanisms involved in pulmonary inflammatory processes as well as pharmacodynamic analysis of investigational drugs for the treatment of respiratory diseases. Aim of this work was to describe the transcriptomic profile of the human segmental LPS challenge model with contextualization to major respiratory diseases. Pre-challenge bronchoalveolar lavage fluid (BAL) and biopsies were sampled from twenty-eight smoking, healthy subjects, followed by segmental LPS challenge and saline control challenge. Twenty-four hours post instillation, BAL and biopsies were collected from the challenged lung segments. Total RNA of cells from BAL and biopsy samples were sequenced for subsequent data analysis. Differential gene expression analysis resulted in 6316 upregulated differentially expressed genes (DEGs) and 241 downregulated DEG in BAL, but only one downregulated DEG in biopsy samples after LPS challenge compared to saline challenge. Upregulated DEG in BAL were related to molecular functions such as “Inflammatory response” or “antimicrobial humoral immune response mediated by antimicrobial peptide”, enriched biological processes such as “chemokine receptor activity”, and upregulated pro-inflammatory pathways such as “Wnt signaling pathway”, “Ras signaling pathway” or “JAK-STAT signaling pathway”. Furthermore, the segmental LPS challenge model resembled aspects of the five most prevalent respiratory diseases chronic obstructive pulmonary disease (COPD), asthma, pneumonia, tuberculosis and lung cancer and featured similarities with acute exacerbations in COPD (AECOPD) and community-acquired pneumonia (CAP). Overall, our study provides extensive information about the transcriptomic profile from BAL cells and mucosal biopsies following LPS challenge in healthy smokers. It expands the knowledge about the LPS challenge model providing potential overlap with respiratory diseases in general and infection-triggered respiratory insults such as AECOPD in particular.
2024-03-01 | E-MTAB-13318 | biostudies-arrayexpress
Project description:Our study discusses the importance of studying sex-specific differences in the response of the airway epithelium to chronic injury. It focuses on tracheal epithelial cells from male and female mice exposed to chronic cigarette smoke and found evidence of sex-specific differences in gene expression and epithelial plasticity. Understanding these differences could lead to more effective personalized treatments for respiratory diseases.
2023-11-15 | GSE229038 | GEO
Project description:Chronic respiratory diseases are a growing burden, and potentially life-threatening condition if left untreated. It is an urgent medical concern that requires proper diagnosis, treatment, and management to prevent serious complications. Analyzing induced sputum is a non-invasive approach for investigating the mechanisms and progression of respiratory diseases. It allows for the collection of sputum samples without disrupting the patient's normal life. By analyzing the proteins and other molecular substances present in the sputum, it can provide valuable insights into the pathological changes and evaluate the effectiveness of treatments for respiratory diseases. In this study, we carried out proteomic analysis of three types of sputum collected from patients with chronic respiratory diseases using three different digestion methods. In comparison, FASP method was found to be more efficient than In-gel digestion and in-solution digestions, yielding the highest number of unique protein identifications. Integrate the proteomic and phosphoproteomic profiling of three types of sputum, it was observed that raw sputum samples exhibited a higher number of unique protein and phosphoprotein identifications. Our study provides valuable insights into the application of proteomics to the analysis of sputum samples, and serves as a useful resource for understanding the potential of this approach in the study of respiratory diseases.
2023-01-28 | PXD039725 |
Project description:This series includes a 32-array training dataset used to evaluate E-Predict normalization and similarity metric parameters as well as 13 microarrays used as examples in (Urisman, et. al 2005). Training data set includes 15 independent HeLa RNAhybridizations (microarrays 1-15), 10 independent nasal lavage samples positive for Respiratory Syncytial virus (microarrays 16-25), and 7 independent nasal lavage samples positive for Influenza A virus (microarrays 26-32). Examples iclude a serum sample positive for Hepatitis B virus (microarray 33), a nasal lavage sample positive for both Influenza A virus and Respiratory Syncytial virus (microarray 34), and culture samples of 11 distinct Human Rhinovirus serotypes (microarrays 35-45). Keywords = virus detection, E-Predict, species identification, metagenomics Keywords: other
2005-03-01 | GSE2228 | GEO